MEPOLIZUMAB

50431 reported adverse events

Drug classes: Interleukin-5 Antagonist [EPC]

These side effects are most commonly reported by patients taking MEPOLIZUMAB:

# Side effect Count
0 ASTHMA 12892
1 DYSPNOEA 10717
2 WHEEZING 7204
3 PRODUCT DOSE OMISSION ISSUE 6869
4 COUGH 5147
5 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5092
6 DRUG INEFFECTIVE 4736
7 PNEUMONIA 4726
8 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4281
9 FATIGUE 3151
See all common reactions for MEPOLIZUMAB

MEPOLIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PLETHYSMOGRAPHY 25 0.9615
1 TOTAL LUNG CAPACITY INCREASED 187 0.6875
2 SPUTUM CULTURE 25 0.6757
3 HEART SOUNDS 63 0.6562
4 AIRWAY REMODELLING 69 0.5565
5 HEPATIC ENZYME 80 0.5369
6 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 261 0.4990
7 REVERSIBLE AIRWAYS OBSTRUCTION 226 0.4449
8 VITAL CAPACITY DECREASED 184 0.4107
9 TOTAL LUNG CAPACITY ABNORMAL 153 0.3933
See all enriched reactions for MEPOLIZUMAB